Regulating new drugs in India needs to be improved
| dc.contributor.author | Peter Roderick | |
| dc.date.accessioned | 2024-12-30T04:05:12Z | |
| dc.date.available | 2024-12-30T04:05:12Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | The authors point out that drug regulatory responsibilities in the country are divided between the national regulator, the Central Drugs Standards Control Organization (CDSCO), and the states. | |
| dc.identifier.uri | https://resourcerepository.azimpremjiuniversity.edu.in/handle/apurr/1355 | |
| dc.publisher | The Lancet Regional Health - Southeast Asia | |
| dc.source.uri | https://doi.org/10.1016/j.lansea.2023.100144 | |
| dc.subject | Drug regulation | |
| dc.subject | Health policy | |
| dc.title | Regulating new drugs in India needs to be improved | |
| dc.type | Comments |